छोड़कर सामग्री पर जाएँ

USFDA accepts Dr Reddy#39;s Biologics License Application for review; stock dips

Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets.

Read More

​ Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets. Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी